A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Triangle Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00044135
First received: August 20, 2002
Last updated: June 23, 2005
Last verified: November 2002
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Study Completion Date: No date given
  Primary Completion Date: No date given